The company is a unit of Johnson & Johnson that manufactures Sedasys, a computer-assisted sedation system that lets physicians and nurses provide propofol sedation during colonoscopy and endoscopy of the upper GI tract.
The use of propofol is generally limited to anesthesiologists, who are trained to administer general anesthesia. Sedasys would allow non-anesthesiologist physicians and nurses to use the system without an anesthesiologist present.
The FDA rejected the device in 2010 after voted 8-2 in favor of approval in 2009. Ethicon Endo-Surgery filed an appeal with FDA Commissioner Margaret Hamburg, MD, and the FDA granted a hearing for the company before the dispute resolution committee in December.
Related Articles on Anesthesia:
Global Anesthesia Disposables Market to Reach $343.5M by 2017
Commentary: Anesthesiologists Should Take Active Role in Drug Safety Shortages
How Will the Affordable Care Act Affect Anesthesiologists After the Supreme Court Rules?
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.